Orion Biotech Opportunities Corp. Warrant
ORIAW
ORIAW was delisted on the 28th of April, 2023.
29 hedge funds and large institutions have $2.25M invested in Orion Biotech Opportunities Corp. Warrant in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
3% more capital invested
Capital invested by funds: $2.18M → $2.25M (+$67.9K)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
6% less funds holding
Funds holding: 31 → 29 (-2)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$29.3K |
| 2 |
Jane Street
New York
|
+$8.53K |
| 3 |
JFG
Jefferies Financial Group
New York
|
+$2.11K |
| 4 |
DCM
DG Capital Management
New York
|
+$39 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
-$36K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$12K |
| 3 |
CF
Cantor Fitzgerald
New York
|
-$6.74K |
| 4 |
SC
Sculptor Capital
New York
|
-$3.68K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1K |
ORIAW Hedge Fund Activity: Q4 2022 in Review
29 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Warrant (ORIAW) for Q4 2022, worth a combined $2.25M — up 3.1% from $2.18M a quarter earlier.
Fund positioning in ORIAW was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was Periscope Capital, adding an estimated $29.3K. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $36K sold.
- 29 institutional investors held Orion Biotech Opportunities Corp. Warrant (ORIAW) as of Q4 2022, down from 31 in Q3 2022.
- Funds reported $2.25M of Orion Biotech Opportunities Corp. Warrant stock for Q4 2022, up 3.1% quarter-over-quarter.
- 3 funds opened new Orion Biotech Opportunities Corp. Warrant positions in Q4 2022 and 3 closed out, a net change of 0 holders.
- The largest Orion Biotech Opportunities Corp. Warrant buyer in Q4 2022 was Periscope Capital, an estimated $29.3K added.
- The largest Orion Biotech Opportunities Corp. Warrant seller in Q4 2022 was Fir Tree Capital Management, an estimated $36K sold.
Based on aggregated 13F filings for Q4 2022.